tirzepatide vs semaglutide cardiovascular outcomes of and for patients with type 2 diabetes in clinical practice Trying to hit your goal

JCI Insight 5 , e138881 (2020)

Heres how the two compare at a glance: Brand names: Wegovy vs Mounjaro Active ingredient: Semaglutide vs Tirzepatide Agonist type: GLP-1 only vs Dual GLP-1/GIP UK weight management approval: September 2022 vs Late 2023 Standard dose range: 0.25mg to 2.4mg (Wegovy) vs 2.5mg to 15mg (Mounjaro) High-dose options: 7.2mg (emerging) vs 15mg (established) The standard approach for both involves gradual escalation from a lower dose to allow your body adjusts to the medication

Quick Facts & Key Specifications This package contains five 50mg vials of lyophilized GHK-Cu for qualified laboratory research

Senduran N, Yadav HN, Vishwakarma VK, Bhatnagar P, Gupta P, Bhatia J, et al